Early clinical evidence suggests that the JAK inhibitor could reduce the number of patients requiring intensive care and mechanical ventilation
News
Sanofi unveils new data for Dupixent in children with dermatitis
Nearly three times as many children achieved clear or almost clear skin when treated with Dupixent and standard-of-care topical corticosteroids
Funding support for community pharmacy during coronavirus
The advanced funding injection is designed to support pharmacies to provide critical services throughout the pandemic
Health secretary lays out plans for 100,000 coronavirus tests a day
Testing for those with a medical need and the most critical workers is to rise to 25,000 a day by mid-to-late April
UK team close to delivering new COVID-19 test
It is hoped that the new technology will deliver up to 1,000 test results per machine in 24 hours
Gilead starts late-stage trials in the UK of potential COVID-19 therapy
The study will initially involve 15 sites across the UK
NIHR launches new Centre for Engagement and Dissemination
The Centre will bring activities in patient and public involvement, engagement and participation and research dissemination under one roof.
AZ licences Movantik rights to RedHill
AstraZeneca has completed its deal to sublicense certain rights to Movantik to RedHill Biopharma
Positive early data from siltuximab COVID-19 trial
One-third (33%) of patients experienced a clinical improvement with a reduced need for oxygen support
NICE publishes second set of rapid COVID-19 guidelines
The guidelines advise clinicians on modifying care to reduce patients’ exposure to COVID-19 and how to balance the risks and benefits of treatment during the pandemic
EU research-based industry unveils COVID-19 commitments
As of this morning – Wednesday April 1 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 25,150, with 1,789 deaths.
Ethris, Neurimmune work on inhalable COVID-19 therapy
Ethris GmbH and Neurimmune AG are working together on developing an inhalable treatment for COVID-19
Novel micro-RNA therapeutic hits early targets in ischemic heart diseases
Earlier this year, Horizon announced a new collaboration and license agreement with Mammoth Biosciences.
Eli Lilly, Sitryx announce autoimmune alliance
Eli Lilly recently announced plans to postpone most new COVID-19-unrelated study starts.
2020 Marketer of the Year competition opens its doors for entry
The long-standing competition is now open for entry to pharma marketers in a variety of roles and experience levels.
